Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA Study

Published:2021-07-18 Issue:4 Volume:110 Page:1075-1086
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Schlichtig Katja¹²,Dürr Pauline¹²³,Dörje Frank²³,Fromm Martin F.¹²

Affiliation:

1. Institute of Experimental and Clinical Pharmacology and Toxicology Friedrich‐Alexander‐Universität Erlangen‐Nürnberg Erlangen Germany

2. Comprehensive Cancer Center Erlangen‐EMN Erlangen University Hospital Erlangen Germany

3. Pharmacy Department Erlangen University Hospital Erlangen Germany

Funder

Deutsche Krebshilfe

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2338

Reference46 articles.

1. NCCN Task Force Report: Oral Chemotherapy

2. 2013 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards Including Standards for the Safe Administration and Management of Oral Chemotherapy

3. Overview of the changing paradigm in cancer treatment: Oral chemotherapy

4. Patient preferences for oral versus intravenous palliative chemotherapy.

5. New oral anti‐cancer drugs and medication safety;Schlichtig K.;Dtsch. Arztebl. Int.,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program;The Oncologist;2024-09-14

2. A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center;JCO Oncology Practice;2024-09

3. Impact of pharmacist-led interventions on medication-related problems among patients treated for cancer: A systematic review and meta-analysis of randomized control trials;Research in Social and Administrative Pharmacy;2024-05

4. From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy;Clinical Pharmacology & Therapeutics;2024-04-24

5. Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System;Pharmacoepidemiology and Drug Safety;2023-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3